Search
Amneal Pharmaceuticals Inc
AMRXAdd to Watchlist
19.450USD
-0.500-2.51%
Close 11-05 16:00（ET）
6.77BMarket Cap
50.16P/E TTM
Amneal Pharmaceuticals Inc (AMRX) Stock Price Target & Forecast
Analyst Rating
Based on 7 analysts giving stock ratings to Amneal Pharmaceuticals Inc in the past month.
Buy
3 Strong Buy
4 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
23.629USD+9.85%
AMRX Analyst Recommendation Trends
In the current month, AMRX has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. AMRX average Analyst price target in the last month is 23.629.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
3
3
1
0
0
0
0
0
4
4
4
4
5
5
5
5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7
7
5
4
5
5
5
5
AMRX Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
8
16
12
1
0
37
Amgen Inc
AMGN
4
9
19
3
1
36
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Eli Lilly and Co
LLY
10
19
3
1
0
33
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
AbbVie Inc
ABBV
8
18
6
0
0
32
Merck & Co Inc
MRK
7
16
8
0
0
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Gilead Sciences Inc
GILD
7
18
5
0
0
30
Bristol-Myers Squibb Co
BMY
5
6
18
1
0
30
Financial Forecasting
Based on analysts' estimates, AMRX EPS is projected to reach 0.233 in FY2026Q4, following reported EPS of -0.065 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
0.17
0.22
0.23
0.23
0.26
Actual
0.20
0.18
-0.06
--
--
Surprise
+15.88%
-18.44%
-127.72%
--
--
FAQs
What is Amneal Pharmaceuticals Inc's expected revenue for the next quarter?
Amneal Pharmaceuticals Inc's expected revenue is 834.52M.
What is Amneal Pharmaceuticals Inc's price target?
Analysts forecast that Amneal Pharmaceuticals Inc's price target is USD 23.91, with the highest forecast at USD 27.00 and the lowest forecast at USD 20.00.
How have Amneal Pharmaceuticals IncAMRX's recent earnings per share performed?
The market expectation was USD -0.06, while Amneal Pharmaceuticals IncAMRX's earnings per share (EPS) for the previous quarter was USD 0.18. EPS for the next quarter is expected at USD 0.23.
What is the analyst rating for Amneal Pharmaceuticals Inc?
Based on the ratings of Amneal Pharmaceuticals Inc's stock from 7 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.